Visit Publisher Site

Venetoclax approved for some patients with Chronic Lymphocytic Leukemia

Share on Facebook   Share on Twitter
(0 Reviews)
Venetoclax approved for some patients with Chronic Lymphocytic Leukemia
Hematologic cancer called chronic lymphocytic leukemia causes aberrant B-cells to increase and accumulate in the blood, bone marrow, and lymphatic tissue, eventually impairing the immune system.

Posted on 09/20/22

Featured Websites







Copyright © 2020 Linkz